APLMW (Apollomics) Other Current Payables: $1.79 Mil (As of Dec. 2025)


APLMW Apollomics Inc APLMW
31 GF Score
Price $0.01
! 4 Warning Signs
View Full Analysis

What is Apollomics Other Current Payables?

Apollomics APLMW 31 Other Current Payables is $1.79 Mil as of Dec. 2025. GuruFocus rates APLMW with a GF Score™ of 31/100. The stock has 4 warning signs investors should review.

Apollomics's Other Current Payables for the quarter that ended in Dec. 2025 was $1.79 Mil.

Apollomics's quarterly Other Current Payables increased from Dec. 2024 ($1.25 Mil) to Jun. 2025 ($9.37 Mil) but then declined from Jun. 2025 ($9.37 Mil) to Dec. 2025 ($1.79 Mil).

Apollomics's annual Other Current Payables declined from Dec. 2023 ($5.97 Mil) to Dec. 2024 ($1.25 Mil) but then increased from Dec. 2024 ($1.25 Mil) to Dec. 2025 ($1.79 Mil).

Apollomics Other Current Payables Related Terms

Apollomics Other Current Payables Historical Data

* Premium members only.

The historical data trend for Apollomics's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Apollomics Other Current Payables Chart

Apollomics Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Payables
Get a 7-Day Free Trial 6.01 7.54 5.97 1.25 1.79

Apollomics Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 5.97 3.07 1.25 9.37 1.79
APLMW
31GF Score
Apollomics Inc APLMW
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Apollomics Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of $1.79 Mil mean?
Apollomics (APLMW) has a Other Current Payables of $1.79 Mil as of Dec. 2025. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Apollomics and its competitors.
Is Apollomics' Other Current Payables too high?
Apollomics' current Other Current Payables is $1.79 Mil. Overall, Apollomics has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Apollomics' Other Current Payables compare to HYPD and MGX?
Apollomics' Other Current Payables of $1.79 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Biotechnology company?
A good Other Current Payables depends on the Biotechnology industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Apollomics and its competitors. Apollomics's current Other Current Payables is $1.79 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apollomics stock overvalued right now?
Apollomics (APLMW) has a current Other Current Payables of $1.79 Mil. The current Other Current Payables is $1.79 Mil. Apollomics' overall GF Score™ is 31/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Apollomics (APLMW), the current Other Current Payables is $1.79 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Apollomics Business Description

Other Exchanges APLM:USA
Address 989 East Hillsdale Boulevard, Suite 220, Foster, CA, USA, 94404
Apollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company programs include vebreltinib (APL-101), selective c-Met inhibitor for the treatment of non-small cell lung cancer and other tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia. Company has three new immuno-oncology product candidates: APL-501, APL-502 and APL-801 include mono-specific and bi-specific antibodies to fight against cancer.
31GF Score

Get the complete analysis for APLMW

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.01
Price